DK0885014T3 - Farmaceutiske præparater indeholdende bufrede orthoesterpolymerer - Google Patents
Farmaceutiske præparater indeholdende bufrede orthoesterpolymererInfo
- Publication number
- DK0885014T3 DK0885014T3 DK97906128T DK97906128T DK0885014T3 DK 0885014 T3 DK0885014 T3 DK 0885014T3 DK 97906128 T DK97906128 T DK 97906128T DK 97906128 T DK97906128 T DK 97906128T DK 0885014 T3 DK0885014 T3 DK 0885014T3
- Authority
- DK
- Denmark
- Prior art keywords
- pharmaceutical compositions
- compositions containing
- containing buffered
- acid
- orthoester
- Prior art date
Links
- 229920000642 polymer Polymers 0.000 title abstract 3
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 150000002905 orthoesters Chemical class 0.000 title 1
- 239000002253 acid Substances 0.000 abstract 2
- 125000002092 orthoester group Chemical group 0.000 abstract 2
- 239000007853 buffer solution Substances 0.000 abstract 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
- 238000013270 controlled release Methods 0.000 abstract 1
- 238000000354 decomposition reaction Methods 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 229940124597 therapeutic agent Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
- A61K9/204—Polyesters, e.g. poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Inorganic Chemistry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Absorbent Articles And Supports Therefor (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP96103391 | 1996-03-05 | ||
| PCT/EP1997/000906 WO1997032606A1 (en) | 1996-03-05 | 1997-02-26 | Pharmaceutical compositions containing buffered ortho ester polymers |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0885014T3 true DK0885014T3 (da) | 2003-02-24 |
Family
ID=8222532
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK97906128T DK0885014T3 (da) | 1996-03-05 | 1997-02-26 | Farmaceutiske præparater indeholdende bufrede orthoesterpolymerer |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US6440460B1 (da) |
| EP (1) | EP0885014B1 (da) |
| JP (1) | JP4225570B2 (da) |
| KR (1) | KR100441821B1 (da) |
| AT (1) | ATE226450T1 (da) |
| AU (1) | AU722303C (da) |
| DE (1) | DE69716586T2 (da) |
| DK (1) | DK0885014T3 (da) |
| ES (1) | ES2185911T3 (da) |
| PT (1) | PT885014E (da) |
| WO (1) | WO1997032606A1 (da) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030040790A1 (en) | 1998-04-15 | 2003-02-27 | Furst Joseph G. | Stent coating |
| US20020099438A1 (en) * | 1998-04-15 | 2002-07-25 | Furst Joseph G. | Irradiated stent coating |
| US8070796B2 (en) | 1998-07-27 | 2011-12-06 | Icon Interventional Systems, Inc. | Thrombosis inhibiting graft |
| US7967855B2 (en) | 1998-07-27 | 2011-06-28 | Icon Interventional Systems, Inc. | Coated medical device |
| US7168489B2 (en) * | 2001-06-11 | 2007-01-30 | Halliburton Energy Services, Inc. | Orthoester compositions and methods for reducing the viscosified treatment fluids |
| US8016881B2 (en) | 2002-07-31 | 2011-09-13 | Icon Interventional Systems, Inc. | Sutures and surgical staples for anastamoses, wound closures, and surgical closures |
| MXPA05002632A (es) | 2002-09-09 | 2005-09-20 | Nektar Therapeutics Al Corp | Metodo para preparar derivados de polimeros solubles en agua que portan un acido carboxilico terminal. |
| US7497278B2 (en) | 2003-08-14 | 2009-03-03 | Halliburton Energy Services, Inc. | Methods of degrading filter cakes in a subterranean formation |
| US7691381B2 (en) * | 2004-04-15 | 2010-04-06 | Allergan, Inc. | Stabilized biodegradable neurotoxin implants |
| US20060200048A1 (en) * | 2005-03-03 | 2006-09-07 | Icon Medical Corp. | Removable sheath for device protection |
| ES2986867T3 (es) | 2005-03-03 | 2024-11-12 | Mirus Llc | Aleaciones metálicas mejoradas para dispositivos médicos |
| US9107899B2 (en) | 2005-03-03 | 2015-08-18 | Icon Medical Corporation | Metal alloys for medical devices |
| WO2006110197A2 (en) | 2005-03-03 | 2006-10-19 | Icon Medical Corp. | Polymer biodegradable medical device |
| US7540995B2 (en) | 2005-03-03 | 2009-06-02 | Icon Medical Corp. | Process for forming an improved metal alloy stent |
| ES2477993T3 (es) * | 2006-11-09 | 2014-07-18 | Alcon Research, Ltd. | Matriz de polímero insoluble en agua para el suministro de fármaco |
| US20080114076A1 (en) * | 2006-11-09 | 2008-05-15 | Alcon Manufacturing Ltd. | Punctal plug comprising a water-insoluble polymeric matrix |
| US20110293549A1 (en) | 2009-02-03 | 2011-12-01 | Athena Cosmetics, Inc. | Composition, method and kit for enhancing hair |
| US8398916B2 (en) | 2010-03-04 | 2013-03-19 | Icon Medical Corp. | Method for forming a tubular medical device |
| BR112016030273A2 (pt) | 2014-06-24 | 2017-08-22 | Icon Medical Corp | Dispositivo médico e método para formar o referido dispositivo |
| US11766506B2 (en) | 2016-03-04 | 2023-09-26 | Mirus Llc | Stent device for spinal fusion |
| CN118903385A (zh) | 2017-08-24 | 2024-11-08 | 诺和诺德股份有限公司 | Glp-1组合物及其用途 |
| PE20230819A1 (es) | 2020-02-18 | 2023-05-19 | Novo Nordisk As | Composiciones y usos de glp-1 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4093709A (en) * | 1975-01-28 | 1978-06-06 | Alza Corporation | Drug delivery devices manufactured from poly(orthoesters) and poly(orthocarbonates) |
| US4010196A (en) * | 1975-06-25 | 1977-03-01 | American Home Products Corporation | Linear polyester salts |
| US4268643A (en) * | 1979-10-25 | 1981-05-19 | Societa Italiana Resine S.I.R. S.P.A. | Process for improving the stability of acetal polymers |
| US4346709A (en) * | 1980-11-10 | 1982-08-31 | Alza Corporation | Drug delivery devices comprising erodible polymer and erosion rate modifier |
| EP0052916B1 (en) * | 1980-11-10 | 1985-01-02 | Alza Corporation | Erodible polymer containing erosion rate modifier |
| DE3642662A1 (de) * | 1986-10-02 | 1988-04-14 | Hoechst Ag | Parenterale depotzubereitungen von regulatorischen peptiden enthaltend calciumacetat-glycerin-addukt, verfahren zu ihrer herstellung sowie die verwendung des addukts |
| US5030457A (en) | 1989-08-28 | 1991-07-09 | Pharmaceutical Delivery Systems, Inc. | Bioerodible polymers useful for the controlled release of therapeutic agents |
| WO1991003510A1 (en) | 1989-08-28 | 1991-03-21 | Pharmaceutical Delivery Systems, Inc. | Bioerodible polymers useful for the controlled release of therapeutic agents |
| WO1993000383A1 (en) | 1991-06-20 | 1993-01-07 | Pharmaceutical Delivery Systems, Inc. | Pulsed release of high molecular weight therapeutic agents from bioerodible polymer compositions |
| US5700485A (en) * | 1992-09-10 | 1997-12-23 | Children's Medical Center Corporation | Prolonged nerve blockade by the combination of local anesthetic and glucocorticoid |
| US5869079A (en) * | 1995-06-02 | 1999-02-09 | Oculex Pharmaceuticals, Inc. | Formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents |
-
1997
- 1997-02-26 AU AU20934/97A patent/AU722303C/en not_active Ceased
- 1997-02-26 PT PT97906128T patent/PT885014E/pt unknown
- 1997-02-26 ES ES97906128T patent/ES2185911T3/es not_active Expired - Lifetime
- 1997-02-26 AT AT97906128T patent/ATE226450T1/de not_active IP Right Cessation
- 1997-02-26 EP EP97906128A patent/EP0885014B1/en not_active Expired - Lifetime
- 1997-02-26 KR KR10-1998-0706905A patent/KR100441821B1/ko not_active IP Right Cessation
- 1997-02-26 DK DK97906128T patent/DK0885014T3/da active
- 1997-02-26 DE DE69716586T patent/DE69716586T2/de not_active Expired - Fee Related
- 1997-02-26 JP JP53141397A patent/JP4225570B2/ja not_active Expired - Fee Related
- 1997-02-26 US US09/117,359 patent/US6440460B1/en not_active Expired - Fee Related
- 1997-02-26 WO PCT/EP1997/000906 patent/WO1997032606A1/en active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| ATE226450T1 (de) | 2002-11-15 |
| EP0885014A1 (en) | 1998-12-23 |
| AU2093497A (en) | 1997-09-22 |
| US6440460B1 (en) | 2002-08-27 |
| KR19990087477A (ko) | 1999-12-27 |
| WO1997032606A1 (en) | 1997-09-12 |
| JP4225570B2 (ja) | 2009-02-18 |
| ES2185911T3 (es) | 2003-05-01 |
| DE69716586D1 (de) | 2002-11-28 |
| PT885014E (pt) | 2003-02-28 |
| EP0885014B1 (en) | 2002-10-23 |
| JP2000506148A (ja) | 2000-05-23 |
| DE69716586T2 (de) | 2003-07-17 |
| AU722303B2 (en) | 2000-07-27 |
| KR100441821B1 (ko) | 2004-10-15 |
| AU722303C (en) | 2001-12-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0885014T3 (da) | Farmaceutiske præparater indeholdende bufrede orthoesterpolymerer | |
| DE69434258D1 (de) | Mikroverkapselte 1,2-benzazole | |
| MX2008000099A (es) | Composiciones farmaceuticas de liberacion modificada novedosas, y procedimiento de preparacion de dichas composiciones. | |
| HK1027979A1 (en) | Indole derivatives and their use as mcp-1 antagonists | |
| PT1144459E (pt) | Acidos hialuronicos reticulados e as suas utilizacoes em medicina | |
| DE69721481D1 (de) | Wirkstoffformulierungen mit verzögerter freisetzung | |
| NO20000284D0 (no) | Tanninsyre-polymerblandinger for kontrollert frigivelse av farmasoeytiske midler, saerlig i munnhulen | |
| NO20002547D0 (no) | Poly(vinylamin)-baserte superabsorberende geler og fremgangsmÕte for fremstilling derav | |
| DE69727956D1 (de) | Pharmazeutische zubereitungen zur verminderung von atmungsdepressionen | |
| GR1003658B (el) | Δισκιο μητρας που καθιστα δυνατη την παρατεταμενη απελευθερωση της τριμεταζιδινης μετα χορηγηση δια της στοματικης οδου | |
| MY129437A (en) | Drug formulation having controlled release of active compound | |
| IS1985B (is) | Lyfjafræðilegar örkúlur með valprósýru til inngjafar um munn | |
| AR021934A1 (es) | Composicion de administracion oral con liberacion controlada de al menos un analgesico | |
| HK1043945A1 (en) | Pharmaceutical capsule compositions containing loratadine and pseudoephedrine. | |
| BR0311642A (pt) | Formulação de divalproex de sódio de liberação aumentada | |
| AU2773597A (en) | Pharmaceutical compositions for the sustained release of insoluble active principles | |
| ATE203665T1 (de) | Stabilisierte pharmazeutische zusammensetzungen und verfahren zu ihrer herstellung | |
| HU9700661D0 (en) | Use of alpha-1-adrenoreceptor antagonists for profilacting and treating cancer | |
| PT1017681E (pt) | Derivados de hidrazono-benzazuleno composicoes farmaceuticas e intermediarios | |
| SE9902742D0 (sv) | New pharmaceutical formultion | |
| CA2243988A1 (en) | Pharmaceutical compositions containing buffered ortho ester polymers | |
| EA200601283A1 (ru) | Фармацевтическая композиция с контролируемым высвобождением, содержащая нерастворимый в кислотах полимер и биоадгезивный полимер | |
| ATE269693T1 (de) | Abführmittel und verfahren zu deren herstellung | |
| NZ521515A (en) | Composition comprising paracetamol and niflumic acid | |
| MX9605633A (es) | Composicion farmaceutica, metodo y dispositivo para prevenir o tratar resequedad de los ojos o enfermedad ocasionada por la misma. |